§ Same category · GLP-1 / metabolic peptides
Semaglutide vs Tirzepatide
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
Semaglutide
0
vendors tracked
Tirzepatide
0
vendors tracked
Semaglutide
GLP-1 agonist for metabolic research
No current listings at 5mg.
Tirzepatide
Dual GLP-1/GIP agonist
No current listings at 10mg.
About Semaglutide
A once-weekly GLP-1 receptor agonist studied for glycemic control and weight loss. Approved as a prescription drug in many jurisdictions; research-peptide vendors supply the compound for laboratory use.
About Tirzepatide
A once-weekly dual GIP and GLP-1 receptor agonist studied for type-2 diabetes and obesity. Approved clinically in many jurisdictions; research-compound form is widely distributed.